Synthesis, biological evaluation and molecular docking study of N -(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists-Reference-Cited by-同舟云学术

Synthesis, biological evaluation and molecular docking study of N -(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists

Published:2017-03 Issue: Volume:129 Page:310-324
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zhou Meng,Luo Rong-Hua,Hou Xue-Yan,Wang Rui-Rui,Yan Guo-Yi,Chen Huan,Zhang Rong-Hong,Shi Jian-You,Zheng Yong-Tang,Li Rui,Wei Yu-Quan

Funder

National Key Program of China

National Natural Science Foundation of China

Innovation Team of Natural Science Foundation of Department of Education of Guizhou Province

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference56 articles.

1. Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G;Rose;AIDS Res Hum. Retroviruses,2005

2. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein;Sheehy;Nature,2002

3. APOBEC3G encapsidation into HIV-1 virions: which RNA is it?;Strebel;Retrovirology,2008

4. Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions;Xu;Virology,2007

5. APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker;Burnett;J. Virol.,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1;Bioorganic & Medicinal Chemistry Letters;2024-10

2. Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction;Viruses;2024-03-22

3. Recent advances in the piperazine based antiviral agents: A remarkable heterocycle for antiviral research;Arabian Journal of Chemistry;2023-12

4. Various strategies for developing APOBEC3G protectors to circumvent human immunodeficiency virus type 1;European Journal of Medicinal Chemistry;2023-03

5. HIV Restriction Factor APOBEC3G and Prospects for Its Use in Gene Therapy for HIV;Molecular Biology;2022-08